Fund profile
K50 Ventures
New York, United States
Leading
About
K50 Ventures, established in 2017 and headquartered in New York, is a venture capital firm dedicated to funding purpose-driven companies at the pre-seed and seed stages. The firm focuses on startups that aim to improve access and affordability in health, finance, and work for the global working class. Notable investments include Mammoth Biosciences, a pioneer in CRISPR technology; Groww, a mobile investing platform in India; and Midi Health, providing specialized healthcare for women over 40. K50 Ventures supports companies that democratize access to financial services, improve healthcare delivery, and empower small businesses and independent workers. Led by founders Ryan Bloomer and Adriel Bercow, K50 Ventures is committed to being the first institutional check and a long-term partner to mission-driven entrepreneurs. They seek founders with a clear vision for creating significant social impact and a solid strategy for execution.
Details
Highlights
$704.5k
Historical average check
$60M
Historical max check
April 2024
Last investment date
169
Investments
Healthtech & Wellness
Software & Apps
Real Estate & Proptech
E-commerce & Retail
Other
Showing 0 lists
Contacts
Lists that include this fund